Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
affective disorders
aggression
agitation
agoraphobia
alcoholic withdrawal states, DT's, convulsions, etc.
aminoacidopathies
aminoacidurias
amnesia, psychogenic
amyotrophic lateral sclerosis
anhedonia
anticoagulant, complications of
anticoagulant, self-monitoring
anticoagulant, treatment
anticoagulant, treatment in CVD
anticoagulation clinic
anticonvulsants
anticonvulsants, untoward effects of
anxiety
artificial intelligence
athetosis
atrial fibrillation
atrial fibrillation, risk stratification
autonomic dysfunction
bacterial infection
bath salts, psychoactive
behavior, combative
behavioral disorder
behavioral disorder, acute
benzodiazepine
blindness
body odor
bruit
bruit, self-audible
burning paresthesia
caffeine
CAG repeats
carbamazepine
carbon monoxide poisoning
case studies
CAT scan, abnormal
CAT scan, myelogram with
cataplexy
causalgia
central nervous system, infection of
cerebral cortical atrophy
cerebral death
cerebrospinal fluid, leak
cerebrospinal fluid, pressure low
cerebrovascular accident
cerebrovascular accident, prevention of
cerebrovascular accident, severity
cervical spine injury
CHADS-VaSC score
children
China
chlordiazepoxide
chorea
cisternogram, radionuclide
Clinical Pathologic Conference(C.P.C.)
clorazepate dipotassium
cognition
cold intolerance
coma
competency
compliance
complications
computers, medicine and
confusion
controversies in neurology
conversion reaction
cost
coumarin
creatine phosphokinase(CPK)elevated
creatinine, elevated
dabigatran
dabigatran, dose
dalmane
degenerative diseases of CNS
delirium
dementia
depression
designer drugs
developmental retardation
diet
dissociative disorder
dizziness
drug abuse
drug abuse, toxic screen In
dying
dysphasia
dyspnea
dystonia
efficacy
electroconvulsive therapy
electroencephalogram
electroencephalogram, abnormalities of
emergencies, neurologic
employment
encephalopathy
encephalopathy, post anoxic
enzyme inhibition
epidural blood patch
ethics in neurology
ethylene glycol
euthanasia
eye color
factor Xa inhibitor
fatigue
fenfluramine
fire setting
fomepizole
fungal infection, CNS
gabapentin
genetic diagnosis, prenatal
genetic neurologic disorders
genetic testing
globus pallidus, lesion of
globus pallidus, lesion of, bilateral
hallucination
hallucination, hypnagogic
HAS-BLED score
head injury
headache
headache, positional
headache, recurrent
health insurance
heart valve, prosthetic
heat intolerance
hemorrhagic diathesis
hospice
Huntington's chorea
Huntington's chorea, genetic counselling
hyperactivity
hyperbaric oxygen
hypersomnia
imbalance
inborn errors of metabolism
incoordination
India
informed consent
INR value, time in range
INR values
intellectual deficit
internet
intracerebral hemorrhage
intracranial hypotension
irritability
laboratory values, normal
lactic acidemia
lamotrigine
level of consciousness, decreased
life support, withdrawal of
life support, withholding of
life sustaining treatment
lumbar puncture, complications of
mania
medical app
medical-legal aspects of neurology
meningeal enhancement
mental retardation
mental status, abnormal
metabolic disorder, primary-screening tests
methanol intoxication
methcathinone
microhemorrhage, intracerebral
miosis
misdiagnosis
modafinil
mogadon
mortality
movement disorder
MRI, abnormal
MRI, contrast enhanced
multiple sclerosis
muscle relaxant
narcolepsy
nausea and vomiting
neck pain
neurologic complications
neurologic complications of, surgery
neurologic disease
neurologic signs
neurologic symptoms
neuropsychiatry
neurosis
neurosis, treatment of
neurotoxin
nightmares
non-vitamin K antagonist oral anticoagulants
oxazepam
oxcarbazepine
pain
pain, back
palliative care
panic attacks
papilledema
paranoia
Parkinsonism syndrome
patient information and support
personality change
phenobarbital
phenylketonuria
photic stimulation
physician assisted suicide
platelet inhibiting drugs
pneumonia
point of care
poison, neurologic problems with
poison, organophosphate
polysomnogram
post traumatic stress disorder
practice guidelines
prevention of neurologic disorders
primary intracranial hypotension
prognosis
psychiatric disorder
psychiatric problems in neurologic disorders
psychosis
psychosis, acute
quadriplegia
quality of life
reflex sympathetic dystrophy
RELY trial
renal failure
renal failure, acute
respirator
review article
rhabdomyolysis
right to die
safety
seizure
seizure, children
seizure, hysterical
seizure, photosensitive
seizure, self-induced
seizure, treatment of
self harm
self monitoring
skin, cherry-red
sleep paralysis
sleep pathology and physiology
smartphone
spinal cord, injury of
stimulant drugs
strychnine poisoning
stuporous
suicidal
suicide
sympathomimetic drugs
systemic lupus erythematosus
systemic lupus erythematosus, neurologic complications with
tiagabine
topiramate
toxic encephalopathy
tracheostomy
trauma
treatment of neurologic disorder
tremor
trigeminal nerve
trigeminal nerve, lesion of
trigeminal neuralgia
trinucleotide repeats
urine test for metabolic disorders
urine test in toxic screen
valium
violent behavior
weight loss
Showing articles 3400 to 3450 of 9369 << Previous Next >>

A Randomized Placebo-Controlled Trial of Rasagiline in Levodopa-Treated Patients with Parkinson Disease and Motor Fluctuations
Arch Neurol 62:241-248, The PRESTO Study, 2005

Patients with Small, Asymptomatic, Unruptured Intracranial Aneurysms and No History of Subarachnoid Hemorrhage Should be Treated Conservatively - Against
Stroke 36:410-411, 407, Weir,W, 2005

Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection Protocol
Stroke 36:602-606, Ribo,M., et al, 2005

Phenytoin Exposure Is Associated With Functional and Cognitive Disability After Subarachnoid Hemorrhage
Stroke 36:583-587, Naidech,A., et al, 2005

Effect of Timing and Method of Enteral Tube Feeding For Dysphagic Stroke Patients (FOOD): a Multicentre Randomised Controlled Trial
Lancet 365:764-772, 729, The FOOD Trial Collaboration, 2005

Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
NEJM 352: 777-785, 828, Mayer, S.A., et al, 2005

Prioritizing interventions to Improve Rates of Thrombolysis for Ischemic Stroke
Neurol 64:654-659, California Acute Stroke Pilot Registry (CASPR) Inv, 2005

Reasons for Exclusion From Thrombolytic Therapy Following Acute Ischemic Stroke
Neurol 64:719-720, Cocho,D., et al, 2005

Spinal Cord Transient Ischemic Attacks: A Possible Role for Abciximab
Neurol 64: 761-762, Hussain, M.S., et al, 2005

Continued Use of Zonisamide Following Development of Renal Calculi
Neurol 64:763-764, Richards, K.C., et al, 2005

Specialist Palliative Care in Dementia
BMJ 330:57-58, Chen,F. & Majeed,A., 2005

Dipyridamole for Preventing Recurrent Ischemic Stroke and Other Vascular Events
Stroke 36:162-168, Leonardi-Bee,J.,et al, 2005

Management of Depression After Stroke
Stroke 36:1092-1097, Hackett,M.L.,et al, 2005

Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1099-1100, 1100, Zivin,J.A., 2005

Acupuncture for Patients with Migraine
JAMA 293:2118-2125, Linde,K.,et al, 2005

Physical Methods for Preventing Deep Vein Thrombosis in Stroke
Stroke 36:1102-1103, Grandi,F.C.,et al, 2005

Myasthenia Gravis
JAMA 293:1940, Torpy,J.M., 2005

Persistent Low Back Pain
NEJM 352:1891-1898, Carragee,E.J., 2005

Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now Be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1098-1099,1100, Schellinger,P.D. &Fiebach,J.B., 2005

Ventriculoperitoneal Shunt in Patients with Leptomeningeal Metastasis
Neurol 64:1625-1627, Omuro,A.M.P.,et al, 2005

IV Thrombolysis in Patients with Acute Stroke Due to Spontaneous Carotid Dissection
Neurol 64:1612-1614, Georgiadis,D.,et al, 2005

Autoantibodies to Folate Receptors in the Cerebral Folate Deficiency Syndrome
NEJM 352:1985-1991, Ramaekers,V.T.,et al, 2005

Pallidal Stimulation Improves Pantothenate Kinase-Associated Neurodegeneration
Ann Neurol 57:738-741,613, Castelnau,P.,et al, 2005

FDA Public Health advisory-Suspended Marketing of Tysabri (natalizumab)
www.fda.gov/cder/drug/advisory/natalizumab.htm.,(Feb 28), US Food and Drug Admin., 2005

Survival after Treatment of Rabies with Induction of Coma
NEJM 352:2508-2514,2549, Willoughby,Jr.,R.E.,et al, 2005

Bells Palsy
BMJ 330:1374, Piercy, J, 2005

Vertigo
BMJ 330:523, Kanagalingam,J.,et al, 2005

Four-Year Outcome after Early Withdrawal of Antiepileptic Drugs in Childhood Epilepsy
Neurol 64:2136-2138, Geerts,A.T.,et al, 2005

Vertebrobasilar Disease
NEJM 352:2618-2626, Savitz,S.I.&Caplan,L.R., 2005

Time to Hospital Arrival, Use of Thrombolytics, and In-Hospital Outcomes in Ischemic Stroke
Neurol 64:2115-2120, Qureshi,A.I.,et al, 2005

Cognitive and Behavioral Effects of Lamotrigine and Topiramate in Healthy Volunteers
Neurol 64:2108-2114, Meador,K.J.,et al, 2005

Practice Parameter:Therapies for Essential Tremor
Neurol 64:2008-2020, Zesiewicz,T.A.,et al, 2005

Numb Ears in Resurrection:Great Auricular Nerve Injury in Hanging Attempt
Neurol 64:2153-2154, Arias,M.,et al, 2005

A Randomized Controlled Trial of Surgery vs Steroid Injection for Carpal Tunnel Syndrome
Neurol 64:2074-2078,2006, Hui,A.C.F.,et al, 2005

Transcranial Low-Frequency Ultrasound-Mediated Thrombolysis in Brain Ischemia
Stroke 36:1441-1446, Daffertshofer,M.,et al, 2005

Houston Paramedic and Emergency Stroke Treatment and Outcomes Study (HoPSTO)
Stroke 36:1512-1518, Wojner-Alexandrov,A.,et al, 2005

Predictors of Early Arterial Reocclusion After Tissue Plasminogen Activator-Induced Recanalization in Acute Ischemic Stroke
Stroke 36:1452-1456, Rubiera,M.,et al, 2005

Safety and Efficacy of Mechanical Embolectomy in Acute Ischemic Stroke, Results of the MERCI Trial
Stroke 36:1432-1440, Smikth,W.D.,et al, 2005

A Simple Score (ABCD) to Identify Individuals at High Early Risk of Stroke After Transient Ischaemic Attack
Lancet 366:29-36, Rothwell,P.M.,et al, 2005

PFO Management:Neurologists vs Cardiologists
Neurol 65:172-173, Messe,S.R.,et al, 2005

Statin Use and the Risk of Incident Dementia
Arch Neurol 62:1047-1051, Rea,T.D.,et al, 2005

Follow-Up of 89 Asymptomatic Patients with Adrenoleukodystrophy Treated with Lorenzos Oil
Arch Neurol 62:1073-1080,1045, Moser,H.W.,et al, 2005

A Floppy Child with Failure to Thrive
Lancet 366:176, Loma-Sanner,I.,et al, 2005

Optic Neuropathy Secondary to Cat Scratch Disease:Distinguishing MR Imaging Features from Other Types of Optic Neuropathies
AJNR 26:1310-1316,1303, Schmalfuss,I.M.,et al, 2005

Spinal Cord Schistosomiasis: MR Imaging Appearance with Surgical and Pathologic Correlation
AJNR 26:1646-1654, Saleem,S.,et al, 2005

An Unusual Case of Growth Retardation
Lancet 366:520, Faleschini,E.,et al, 2005

Prognosis and Decision Making in Severe Stroke
JAMA 294:725-733, Holloway,R.G.,et al, 2005

Effect of Discontinuing Aspirin Therapy on the Risk of Brain Ischemic Stroke
Arch Neurol 62:1217-1220, Maulaz,A.B.,et al, 2005

Supportive Care for Patients With Guillain-Barr Syndrome
Arch Neurol 62:1194-1198, Hughes,R.A.C.,et al, 2005

A Single Dose of Gabapentin Reduces Acute Pain and Allodynia in Patients with Herpes Zoster
Neurol 65:444-447,349, Berry,J.D. &Peterson,K.L., 2005



Showing articles 3400 to 3450 of 9369 << Previous Next >>